(Q73350572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

fluticasone propionate

1 reference

P T Daley-Yates

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Tournant

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R L Kunka

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

39 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

39-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-200039001-00006

3 November 2019

exact match

0 references

cites work

The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers

1 reference

12 December 2020

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

1 reference

12 December 2020

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

1 reference

12 December 2020

Bioavailability of orally administered micronised fluticasone propionate

1 reference

12 December 2020

A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma

1 reference

12 December 2020

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

1 reference

12 December 2020

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

1 reference

12 December 2020

Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction

1 reference

12 December 2020

Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant

1 reference

12 December 2020

Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma

1 reference

12 December 2020

Effects of airway calibre on lung delivery of nebulised salbutamol

1 reference

12 December 2020

10.2165/00003088-200039001-00006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11140432%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference